View in EDS HTML Full Text PDF Full Text

Characterization of Belantamab Mafodotin-Induced Corneal Changes in Patients With Multiple Myeloma.

Saved in:
Bibliographic Details
Title: Characterization of Belantamab Mafodotin-Induced Corneal Changes in Patients With Multiple Myeloma.
Authors: Lee V; Department of Ophthalmology and Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia., Hultcrantz M; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York., Petrone S; GSK, New Hope, Pennsylvania., Lewis EW; GSK, Durham, North Carolina., Banna H; Department of Ophthalmology, University of North Carolina at Chapel Hill., Lichtman E; Division of Hematology, University of North Carolina at Chapel Hill., Thulasi P; Emory University, Atlanta, Georgia.; Now with Ophthalmology and Visual Sciences Division of Cornea and External Disease, Washington University Physicians, St Louis, Missouri., Quick AA; Department of Ophthalmology, University of Kansas Medical Center, Prairie Village., Jeng BH; Ophthalmology and Visual Sciences, University of Maryland, Baltimore.; Now with Department of Ophthalmology and Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia., Sunshine SB; Ophthalmology and Visual Sciences, University of Maryland, Baltimore., Francis JH; Ophthalmic Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Canestraro J; Ophthalmic Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Farooq AV; Department of Ophthalmology and Visual Science, University of Chicago, Chicago, Illinois., Clements P; Pathology, Nonclinical Safety, GSK, Stevenage, United Kingdom., Robertson N; Nonclinical Safety, GSK, Stevenage, United Kingdom., Burman M; Formerly with Department of Genetic Toxicology, GSK, Ware, United Kingdom., McKevitt T; Pathology, Nonclinical Safety, GSK, Stevenage, United Kingdom.; Now with Clinical Pharmacology and Safety Sciences, AstraZeneca, Cambridge, United Kingdom., Struemper H; Clinical Pharmacology Modeling & Simulation, GSK, Durham, North Carolina., Weir L; Nonclinical Safety, GSK, Stevenage, United Kingdom.
Source: JAMA ophthalmology [JAMA Ophthalmol] 2025 Jun 01; Vol. 143 (6), pp. 507-514.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print Cited Medium: Internet ISSN: 2168-6173 (Electronic) Linking ISSN: 21686165 NLM ISO Abbreviation: JAMA Ophthalmol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40338596
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Characterization of Belantamab Mafodotin-Induced Corneal Changes in Patients With Multiple Myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lee+V%22">Lee V</searchLink>; Department of Ophthalmology and Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Hultcrantz+M%22">Hultcrantz M</searchLink>; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Petrone+S%22">Petrone S</searchLink>; GSK, New Hope, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Lewis+EW%22">Lewis EW</searchLink>; GSK, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Banna+H%22">Banna H</searchLink>; Department of Ophthalmology, University of North Carolina at Chapel Hill.<br /><searchLink fieldCode="AU" term="%22Lichtman+E%22">Lichtman E</searchLink>; Division of Hematology, University of North Carolina at Chapel Hill.<br /><searchLink fieldCode="AU" term="%22Thulasi+P%22">Thulasi P</searchLink>; Emory University, Atlanta, Georgia.; Now with Ophthalmology and Visual Sciences Division of Cornea and External Disease, Washington University Physicians, St Louis, Missouri.<br /><searchLink fieldCode="AU" term="%22Quick+AA%22">Quick AA</searchLink>; Department of Ophthalmology, University of Kansas Medical Center, Prairie Village.<br /><searchLink fieldCode="AU" term="%22Jeng+BH%22">Jeng BH</searchLink>; Ophthalmology and Visual Sciences, University of Maryland, Baltimore.; Now with Department of Ophthalmology and Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Sunshine+SB%22">Sunshine SB</searchLink>; Ophthalmology and Visual Sciences, University of Maryland, Baltimore.<br /><searchLink fieldCode="AU" term="%22Francis+JH%22">Francis JH</searchLink>; Ophthalmic Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Canestraro+J%22">Canestraro J</searchLink>; Ophthalmic Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Farooq+AV%22">Farooq AV</searchLink>; Department of Ophthalmology and Visual Science, University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Clements+P%22">Clements P</searchLink>; Pathology, Nonclinical Safety, GSK, Stevenage, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Robertson+N%22">Robertson N</searchLink>; Nonclinical Safety, GSK, Stevenage, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Burman+M%22">Burman M</searchLink>; Formerly with Department of Genetic Toxicology, GSK, Ware, United Kingdom.<br /><searchLink fieldCode="AU" term="%22McKevitt+T%22">McKevitt T</searchLink>; Pathology, Nonclinical Safety, GSK, Stevenage, United Kingdom.; Now with Clinical Pharmacology and Safety Sciences, AstraZeneca, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Struemper+H%22">Struemper H</searchLink>; Clinical Pharmacology Modeling & Simulation, GSK, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Weir+L%22">Weir L</searchLink>; Nonclinical Safety, GSK, Stevenage, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101589539%22">JAMA ophthalmology</searchLink> [JAMA Ophthalmol] 2025 Jun 01; Vol. 143 (6), pp. 507-514.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101589539 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2168-6173 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221686165%22">21686165 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Ophthalmol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40338596
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamaophthalmol.2025.1008
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 507
    Titles:
      – TitleFull: Characterization of Belantamab Mafodotin-Induced Corneal Changes in Patients With Multiple Myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lee V
      – PersonEntity:
          Name:
            NameFull: Hultcrantz M
      – PersonEntity:
          Name:
            NameFull: Petrone S
      – PersonEntity:
          Name:
            NameFull: Lewis EW
      – PersonEntity:
          Name:
            NameFull: Banna H
      – PersonEntity:
          Name:
            NameFull: Lichtman E
      – PersonEntity:
          Name:
            NameFull: Thulasi P
      – PersonEntity:
          Name:
            NameFull: Quick AA
      – PersonEntity:
          Name:
            NameFull: Jeng BH
      – PersonEntity:
          Name:
            NameFull: Sunshine SB
      – PersonEntity:
          Name:
            NameFull: Francis JH
      – PersonEntity:
          Name:
            NameFull: Canestraro J
      – PersonEntity:
          Name:
            NameFull: Farooq AV
      – PersonEntity:
          Name:
            NameFull: Clements P
      – PersonEntity:
          Name:
            NameFull: Robertson N
      – PersonEntity:
          Name:
            NameFull: Burman M
      – PersonEntity:
          Name:
            NameFull: McKevitt T
      – PersonEntity:
          Name:
            NameFull: Struemper H
      – PersonEntity:
          Name:
            NameFull: Weir L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2025 Jun 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2168-6173
          Numbering:
            – Type: volume
              Value: 143
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: JAMA ophthalmology
              Type: main
ResultId 1